Sang-Ku Lee

Title: Sang-Ku Lee: Innovator in Pharmaceutical Compositions

Introduction

Sang-Ku Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various diseases, including cancers.

Latest Patents

Sang-Ku Lee holds 2 patents. His latest patents include a pharmaceutical composition of diaryl-isoxazole derivatives for the prevention and treatment of cancers. This invention focuses on using diaryl-isoxazole derivatives as an effective ingredient to inhibit the metastasis of breast cancer cell lines and angiogenesis. The composition can be utilized not only as a metastasis inhibitor but also for treating diseases related to angiogenesis, such as rheumatoid arthritis and psoriasis. Another notable patent involves flavanone derivatives and a composition for preventing or treating blood lipid level-related diseases.

Career Highlights

Sang-Ku Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work has been instrumental in advancing pharmaceutical research and developing innovative treatments for serious health conditions.

Collaborations

Some of his notable coworkers include Song-Hae Bok and Tae-Sook Jeong, who have collaborated with him on various research projects.

Conclusion

Sang-Ku Lee's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes through research and development. His work continues to pave the way for new treatments in the medical field.